ATC code - L04AA32
PolandApremilast
-
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC code: L04AA32
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited
-
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC code: L04AA32
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited
-
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC code: L04AA32
Manufacturer: Farmaprojects S.A.U.
-
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC code: L04AA32
Manufacturer: Farmaprojects S.A.U.
-
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC code: L04AA32
Manufacturer: Krka, d.d., Novo mesto
-
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC code: L04AA32
Manufacturer: Krka, d.d., Novo mesto
-
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC code: L04AA32
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited
-
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC code: L04AA32
Manufacturer: Adalvo Ltd. Pharmadox Healthcare Limited
-
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC code: L04AA32
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC code: L04AA32
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
Form: tablets, film-coated
Active substance Dosage apremilast 30 mg ATC code: L04AA32
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH
-
Form: tablets, film-coated
Active substance Dosage apremilast 10 mg or 20 mg or 30 mg ATC code: L04AA32
Manufacturer: Lek Pharmaceuticals d.d. Salutas Pharma GmbH